Literature DB >> 1139195

Myasthenia syndrome during penicillamine treatment.

A Czlonkowska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1139195      PMCID： PMC1673956          DOI： 10.1136/bmj.2.5973.726-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  An improved colorimetric enzymatic assay of ceruloplasmin.

Authors:  H A RAVIN
Journal:  J Lab Clin Med       Date:  1961-07

2.  Observations on copper metabolism in Wilson's disease.

Authors:  A Czlonkowska; A Galewicz; M Rodo; H Wehr
Journal:  Acta Univ Carol Med Monogr       Date:  1973
  2 in total
  8 in total

1.  Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.

Authors:  R C Bucknall
Journal:  Proc R Soc Med       Date:  1977

2.  Effects of long-term treatment in Wilson's disease with D-penicillamine and zinc sulphate.

Authors:  A Czlonkowska; J Gajda; M Rodo
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

3.  Letter: Penicillamine therapy, antistriational antibody, and myasthenia gravis.

Authors:  R L Dawkins; P J Zilko; E T Owen
Journal:  Br Med J       Date:  1975-12-27

Review 4.  Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.

Authors:  I A Jaffe
Journal:  Springer Semin Immunopathol       Date:  1981

5.  [Myasthenic syndrome during penicillamine treatment (author's transl)].

Authors:  F Schumm; M Stöhr
Journal:  Klin Wochenschr       Date:  1978-02-01

6.  Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.

Authors:  J P Delamere; S Jobson; L P Mackintosh; L Wells; K W Walton
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

7.  Autoantibodies in Wilson disease: Impact on clinical course.

Authors:  Magdalena Antczak-Kowalska; Anna Członkowska; Ceren Eyileten; Anna Palejko; Agnieszka Cudna; Marta Wolska; Agnieszka Piechal; Tomasz Litwin
Journal:  JIMD Rep       Date:  2022-07-22

8.  Comparison of the Pharmacokinetic Profiles of Trientine Tetrahydrochloride and Trientine Dihydrochloride in Healthy Subjects.

Authors:  Karl Heinz Weiss; Catherine Thompson; Peter Dogterom; Yi-Jin Chiou; Tim Morley; Brinley Jackson; Naseem Amin; Camille Omar Farouk Kamlin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-08-06       Impact factor: 2.441
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.